
|Articles|March 1, 2012
Preventing recurrent urinary tract infections: Is a vaccine still feasible?
David Klumpp, PhD, and David T. Uehling, MD, explain the challenges inherent in developing a vaccine for UTI and discuss the status of current research.
Advertisement
Q. Please discuss how you became interested in a urinary tract infection vaccine.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Cretostimogene Grenadenorepvec: Mechanism and Rationale
5












